Rie Ito* and Fumiko Ohtsu
Attention deficit hyperactivity disorder (ADHD) is a developmental disorder characterized by a lack of attention, hyperactivity, and impulsivity. Intuniv® was used to treat ADHD. The side effects of Intuniv®, including hypotension and sedation (sleepiness and drowsiness), have a significant impact on children’s daily lives. This study aimed to evaluate parents' perceptions of the side effects of Intuniv® at home, nursery schools, kindergartens, and schools. It also aimed to clarify the current state of information sharing between parents and school teachers. We distributed a self-administered survey form to all parents who visited Ito Pharmacy and had a child administered Intuniv®. We investigated the patients' background, whether the schoolteachers were informed by the parents about Intuniv® intake by their children, and the occurrence of side effects of Intuniv® administration. We also examined the means of sharing information between parents and school teachers when side effects occurred. The results revealed that most children experienced serious side effects. Approximately 92.5% of the parents informed the schoolteachers about Intuniv® intake by their children. Parents of children who experienced side effects at school used more frequent means of contact with teachers than those who did not experience side effects at school. Some parents who used frequent means of contact were aware that their children experienced hypotension. Frequent sharing of information with school teachers enables parents to be aware of the occurrence of side effects experienced by their children at school.
HTML PDFShare this article
Journal of Pediatric Neurology and Medicine received 68 citations as per Google Scholar report
